Theriva Biologics (TOVX) Net Equity Issued and Repurchased (2010 - 2025)
Theriva Biologics' Net Equity Issued and Repurchased came in at -$6.69 million for Q4 2025, compared with $1.65 million a year earlier.
Powered by 
Analysis
Theriva Biologics (TOVX) Net Equity Issued and Repurchased (2010 - 2025) Analysis & Trends
For FY2025, Theriva Biologics' Net Equity Issued and Repurchased was $4,000, down 99.9% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -74.0% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $3.6 million in FY2024 (+63.6%), $2.2 million in FY2023 and $65.96 million in FY2021.
- The Q4 2025 figure represents the lowest quarterly Net Equity Issued and Repurchased in data going back to Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Theriva Biologics | 10.56 Mn | 10.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -6.69 Mn |
| Sep 30, 2025 | 6.69 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2021 | 57.96 Mn |
| Mar 31, 2021 | 8.00 Mn |
| Dec 31, 2020 | 3.36 Mn |
| Dec 31, 2018 | 5.75 Mn |
| Sep 30, 2018 | 6.02 Mn |
| Jun 30, 2018 | 400,000.00 |
| Sep 30, 2017 | 444,000.00 |
| Jun 30, 2017 | 5.65 Mn |
| Mar 31, 2017 | 269,000.00 |
| Dec 31, 2016 | 24.37 Mn |
| Sep 30, 2016 | 633,000.00 |
| Dec 31, 2014 | 20.67 Mn |
| Dec 31, 2013 | 13.22 Mn |
| Dec 31, 2012 | 8.85 Mn |
| Sep 30, 2012 | 94,000.00 |
| Jun 30, 2012 | 390,000.00 |
API Access
Theriva Biologics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();